Hong Kong Stock Midday Review | Hang Seng Index fell 0.18% in the morning session, Biopharmaceutical sector strong

Zhitong
2025.05.27 04:05

The Hong Kong Hang Seng Index fell 0.18% in the morning session, reporting 23,241 points, while the Hang Seng Tech Index dropped 0.58%. Pharmaceutical stocks performed strongly, with Junshi Biosciences rising 6% and Lepu Biopharma-B increasing 8%. Several key data points are set to be unveiled at the ASCO conference, enhancing the industry's prosperity for innovative drug BD. ZA ONLINE rose over 5%, and SMOORE INTL increased over 7%. Horizon Robotics-W rose 9%, while Giant Biogene fell over 2%

According to Zhitong Finance APP, the Hong Kong Hang Seng Index fell by 0.18%, down 41 points, closing at 23,241 points; the Hang Seng Tech Index dropped by 0.58%. The Hong Kong stock market saw a turnover of HKD 111.4 billion in the morning session.

Pharmaceutical stocks strengthened in the morning, with several key data points set to be unveiled at the ASCO conference, and innovative drugs boosting industry sentiment. Junshi Biosciences (01877) rose by 6%; Lepu Biopharma-B (02157) increased by 8%; Genscript Biotech (01548) gained 5%; WuXi AppTec (02268) climbed 5%.

He Yu-B (02256) rose over 2%, as Ipatimod received CDE approval for breakthrough therapy designation for HCC.

Yiming Anke-B (01541) increased by over 4%, with results from the IMM2510/AXN-2510 combination chemotherapy Phase II trial expected to be announced in the second half of the year.

ZA ONLINE (06060) rose over 5% again, with its stock price up more than 30% this month, as the company is expected to benefit from the Hong Kong stablecoin bill.

SMOORE INTL (06969) rose over 7% again, with the new generation of heated non-combustible product Glo Hilo set to launch in Japan.

Inspur Digital Enterprise (00596) rose over 7%, as the company is a leading player in China's ERP sector, with institutions stating that its valuation is severely underestimated compared to peers.

Gu Ming (01364) rose over 7% to reach a new high, with expectations to enter the Hong Kong Stock Connect next month, and significant same-store growth in the first quarter.

KEEP (03650) rose over 7%, as the company's smart sports watch is set to be revamped, featuring a major upgrade to its AI running coach function.

Jacobson Pharmaceutical (02633) rose over 5%, with expectations for a more than 10% year-on-year increase in net profit for the fiscal year 2025.

Horizon Robotics-W (09660) rose by 9%, as the company was included in the Hong Kong Stock Connect under the Shenzhen-Hong Kong Stock Connect, with institutions expecting chip shipments to increase year-on-year.

Giant Biologics (02367) fell over 2% again, as its brand Kefu Mei was embroiled in a "fraud scandal," with Citigroup concerned about its performance during the 618 promotion

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.